SCHEMBL6529547

SCHEMBL6529547

COC(=O)[C@@H](CC(C)C)Nc1nc(NCC(O)c2ccccc2)nc(Nc2cccc(F)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPR3 P17342 4/20 0.41
KDM4E B2RXH2 1/20 0.39
ELANE P08246 3/20 0.39
KCNH3 Q9ULD8 3/20 0.38
CDC7 O00311 1/20 0.38
DAPK3 O43293 1/20 0.38
PRKD3 O94806 1/20 0.38
PIM1 P11309 1/20 0.38
CDK2 P24941 1/20 0.38
FLT3 P36888 1/20 0.38
CSNK1A1 P48729 1/20 0.38
GSK3B P49841 1/20 0.38
CDK7 P50613 1/20 0.38
CDK9 P50750 1/20 0.38
PRKX P51817 1/20 0.38
JAK3 P52333 1/20 0.38
CDK5 Q00535 1/20 0.38
MAP4K2 Q12851 1/20 0.38
DYRK1A Q13627 1/20 0.38
MELK Q14680 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6529544 1.00 NPR3 (0.41) NPR3KDM4EELANEKCNH3CDC7
SCHEMBL6530469 0.83 NPR3 (0.55) NPR3ELANEKCNH3CYP2C9CYP2C19
SCHEMBL6530463 0.83 NPR3 (0.55) NPR3ELANEKCNH3CYP2C9CYP2C19
SCHEMBL6529452 0.82 CDC7 (0.44) NPR3ELANEKCNH3CDC7CDK2
SCHEMBL6529455 0.82 CDC7 (0.44) NPR3ELANEKCNH3CDC7CDK2
SCHEMBL6527960 0.81 NPR3 (0.43) NPR3ELANEKCNH3GSK3BCDK5
SCHEMBL6527972 0.81 NPR3 (0.43) NPR3ELANEKCNH3GSK3BCDK5
SCHEMBL6529989 0.81 MEN1 (0.52) NPR3KCNH3CDK2GSK3BCDK5
SCHEMBL6529995 0.81 MEN1 (0.52) NPR3KCNH3CDK2GSK3BCDK5
SCHEMBL6530423 0.79 ALDH1A1 (0.47) KCNH3CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed